Trademark Overview
On Wednesday, August 14, 2024, a trademark application was filed for ONYDA XR with the United States Patent and Trademark Office. The USPTO has given the ONYDA XR trademark a serial number of 98698414. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, August 14, 2024. This trademark is owned by TRIS PHARMA, INC.. The ONYDA XR trademark is filed in the Pharmaceutical Products category with the following description:
PHARMACEUTICAL PREPARATIONS WHICH ACT ON THE CENTRAL NERVOUS SYSTEM, INCLUDING MODIFIED RELEASE AND/OR EXTENDED RELEASE COMPOSITIONS CONTAINING CLONIDINE; PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER, INCLUDING MODIFIED RELEASE AND/OR EXTENDED RELEASE COMPOSITIONS CONTAINING CLONIDINE